The William Harvey Research Institute is currently the UK’s largest academic pharmacological research institute, with 350 scientists and clinicians from more than 40 nations, and has a long history of training talented scientists for careers in cardiovascular sciences and translational research (http://www.whri.qmul.ac.uk/). In the UK Research Assessment Exercise (2014) 90% of our research was rated as world leading or internationally excellent. We are now seeking outstanding life sciences graduates for our BHF funded 4 year MRes/PhD programme to commence in October 2017.
Successful applicants will join our Translational Cardiovascular Academy and undertake an MRes course for the first year of study offering students the foundation knowledge and abilities they will need to proceed to their PhD training. The year will be divided into distinct sections, the first being dedicated to the teaching of essential skills followed by laboratory-based research projects. Upon successful completion of their MRes studies, students will continue to study for a 3 year PhD working with their chosen supervisor within the William Harvey Research Institute or wider medical school and college.
Successful applicants will receive an award covering tuition fees and a bursary at the applicable BHF rates (currently £22,278 for the first year).